Lisa Monteggia: Por qué la depresión no es lo que piensas

Por qué la depresión no es lo que piensas

La idea de que la depresión proviene de un desequilibrio químico en el cerebro ha moldeado el tratamiento durante décadas. La neurocientífica Lisa Monteggia comparte investigaciones que sugieren que esa no es toda la historia... y muestra cómo un fármaco de hace décadas podría revolucionar lo que creíamos saber sobre la depresión, con el potencial de ofrecer alivio en cuestión de horas.

The longstanding belief that depression results from a simple serotonin deficiency is being challenged by new research. While antidepressants like SSRIs do help many, they do not work for everyone and often take weeks to show effects. A decades-old drug, ketamine, has shown the ability to lift severe depression within hours, not by correcting a chemical imbalance but by triggering the brain's adaptability. This shift opens new possibilities for rapid relief and reframes the understanding of mental health treatment.

Depression Is Not Just A Chemical Imbalance After All

The long-held belief that depression stems from a lack of serotonin is being challenged by new research. While SSRIs remain crucial and life-saving for many, studies show that not all people with depression have low serotonin levels. A decades-old drug, ketamine, can rapidly relieve symptoms within hours by triggering the brain to adapt and form new connections. This discovery offers hope for millions facing depression, especially those who have not found relief with traditional treatments.

Depression Is Not Just A Chemical Imbalance

For decades, depression was blamed on a lack of serotonin, driving a chemical imbalance narrative and shaping how millions were treated. Yet evidence shows many with depression have normal serotonin levels, and standard antidepressants take weeks to work. A decades-old drug, ketamine, can lift depressive symptoms within hours by triggering rapid changes in brain connections, not by correcting a chemical deficit. This discovery reframes depression as a problem of brain adaptability, opening new paths for hope and treatment.